Science Bytes

Science Bytes

By Lance PickensScience
Download on the App Store

Science Bytes episodes

  • Starving Glioblastoma: Why Brain Tumor Stem Cells Run on Fat
    Glioblastoma is an aggressive brain cancer that almost inevitably returns after surgery due to resilient cancer stem cells. While most tumors gorge on sugar to grow, recent research reveals that glioblastoma stem cells actually fuel themselves by burning fats. This unexpected metabolic shift suggests that targeting fatty acid oxidation could starve the cancer and prevent it from growing back.
    This episode was generated by AI from the cited research paper.
    16 min
  • How Super El Niño Events Trigger Lasting Climate Shifts
    Recent research reveals that while ordinary El Niño events cause temporary weather disturbances, extreme versions of this phenomenon leave a much longer footprint. When sea surface temperatures in the eastern Pacific spike past critical thresholds, a Super El Niño delivers a massive shock to the global climate system. This perturbation forces ocean temperatures, air temperatures, and soil moisture into entirely new baseline states that can persist for decades.
    This episode was generated by AI from the cited research paper.
    16 min
  • Why Your Thoughts Are Not Made of Words
    For centuries, philosophers have debated whether human thoughts are literally made of words. Recent neuroscience research investigates the human brain to reveal that formal logical reasoning is actually separate from natural language processing. This biological distinction helps explain why modern artificial intelligence models can generate highly articulate text but still struggle with robust logical reasoning.
    This episode was generated by AI from the cited research paper.
    13 min
  • Dyson Spheres Around Dying Stars: Where to Look on the H–R Diagram
    What would an alien Dyson sphere — a shell built to capture a star's entire energy output — actually look like to our telescopes? A single-author study by Amirnezam Amiri models the infrared signatures of these hypothetical megastructures around two often-overlooked host stars: cooling white dwarfs and small, long-lived red M-dwarfs. Hosts Hope and Lauren walk through the radiative-balance argument — why a sphere's equilibrium temperature falls off as the inverse square root of its radius while the star's total luminosity stays fixed, so the intercepted energy simply re-emerges at longer, cooler wavelengths. Placing these objects on the Hertzsprung–Russell diagram turns a science-fiction trope into a concrete observational target: a faint infrared blackbody sitting where no natural star should be. The upshot is that the best place to catch a technosignature may be around the galaxy's dimmest, most durable stars.
    This episode was generated by AI from the cited research paper.
    13 min
  • Tracking Human Evolution Through 15,000 Ancient Genomes
    For the last ten thousand years, human evolution has been running on overdrive to keep up with massive lifestyle changes like farming. By analyzing over 15,000 ancient genomes alongside modern DNA, researchers mapped a giant genetic relationship matrix to separate true Darwinian selection from the noise of migration. This massive dataset reveals hundreds of specific genetic variants that underwent strong directional selection, allowing us to watch West Eurasians adapt in real time.
    This episode was generated by AI from the cited research paper.
    13 min
  • The Lizard, the Hormone, and the Drugs That Ate the World: A GLP-1 Explainer
    How a desert lizard's venom became the best-selling medicines on Earth. We trace the science of GLP-1 receptor agonists from 1990 — when endocrinologist John Eng isolated exendin-4 from Gila monster venom, a hormone that mimics human GLP-1 but lasts hours instead of two minutes — through the drug lineage it spawned: exenatide (Byetta), liraglutide, semaglutide (Ozempic/Wegovy), the dual GIP/GLP-1 agonist tirzepatide (Mounjaro/Zepbound), and the triple agonist retatrutide. Hosts Hope and Lauren unpack the incretin biology and the decades-long "half-life arms race," how each generation pushed diabetes control and weight loss further, and the delightful surprises now emerging in the clinic — cardiovascular protection (SELECT), chronic kidney disease, obstructive sleep apnea, fatty-liver disease, and early signals in cravings and the aging brain — alongside the very real GI side effects that come with them.
    This episode was generated by AI from the cited research paper.
    20 min
  • Low Energy Nuclear Reactions, Part 4: Revival, Theory, and the Road Ahead
    Part 4 of 4, the finale. Cold fusion never quite died — and lately it has been revived by unlikely backers. We trace Google's multi-year, multi-lab investigation and NASA's lattice-confinement work, the newer research programs now funding the field, the stubborn theory gap (there is still no accepted mechanism), and where the most credible next breakthroughs might come from. We close by weighing where the science honestly stands more than thirty-five years after 1989.
    This episode was generated by AI from the cited research paper.
    24 min
  • Low Energy Nuclear Reactions, Part 3: Inside the Lattice
    Part 3 of 4. Cold fusion's most reproducible finding is also its strangest prerequisite: you have to cram deuterium into palladium past a critical loading ratio — roughly 0.85 to 0.90 deuterium atoms per palladium atom — before anything happens at all. We look at what "loading the lattice" really means, why that threshold is so hard to reach and hold, and then at electron screening: the honest, mainstream benchmark for how much a metal's own electrons can shrink the Coulomb barrier, and whether it is anywhere near enough to explain the claims.
    This episode was generated by AI from the cited research paper.
    16 min
  • Low Energy Nuclear Reactions, Part 2: Measuring the Heat, Hunting the Ash
    Part 2 of 4. If cold fusion really released nuclear-scale energy, it should betray itself two ways: as heat you can measure and as nuclear ash you can detect. We dig into calorimetry — how you actually measure excess heat in an electrochemical cell, and the traps (recombination, calibration, open versus closed cells) that make it treacherous — then turn to the hunt for the tell-tale products of fusion: helium, tritium, and neutrons, and why their stubborn near-absence became the field's central puzzle.
    This episode was generated by AI from the cited research paper.
    33 min
  • Low Energy Nuclear Reactions, Part 1: The Barrier and the Bombshell
    Part 1 of 4. Before we can weigh the extraordinary claim of cold fusion, we need the ordinary physics it defies. We build the yardstick: the electrostatic Coulomb barrier that keeps two nuclei apart, the quantum tunneling that rarely lets them through, and the precisely measured rates of deuterium-deuterium fusion. Then we turn to March 1989, when Martin Fleischmann and Stanley Pons announced they had produced nuclear fusion in a tabletop electrochemical cell, igniting one of modern science's great controversies.
    This episode was generated by AI from the cited research paper.
    16 min

About Science Bytes

From the publisher's feed

Bite-sized, two-host deep dives into the research papers behind the headlines. Each episode takes one new study — physics, biology, AI, the cosmos — and turns it into a clear, curious conversation you…